- OralPAS Pro®
- >
- Technologies
- >
- home
OralPAS Pro®
INNOPHARMAX welcomes the opportunities to collaborate with strategic partners on co-development of partners’ assets/drug candidates utilizing INNOPHARMAX’s core drug delivery platforms OralPAS and OralPAS Pro
Inquiry on collaboration and additional information:business@innopharmax.com
OralPAS Pro® platform, is a solid-SMEDDS dosage form composed of peptide drug, solvent, co-solvent, and surfactant adsorbed onto granules by inert excipients. Once platform is exposed to the fluids of gastrointestinal (GI) tract, peptide drug, surfactant and co-solvent are released from granules, and then rapidly spontaneously emulsify to form very fine globules (size, 100-200 nm) which entrap peptide drug in the nanoemulsion droplet core to against enzyme degradation and to enhance permeability, resulting in improvement of peptide drugs absorption through oral administration.